Michiel van de Ven (@mivandev) profile picture

Health Economist | HTA | Simulation modeling | Data science | Research

Joined December 2020
There's still time to register for our virtual course on Discrete Event Simulation in R to support #healthcare #decisionmaking. We are looking forward to seeing you! 👉 https://nitter.cf/t.co/ngm2FENDH2 ⏰ Thur 28 Feb at 7AM PST | 10AM EST | 4PM CET @ErikKoffijberg @k_degeling @mivandev
2
4
10
1,298
Would you like to learn more about Discrete Event Simulation in R to support #healthcare #decisionmaking? Join our upcoming online course 👉 https://nitter.cf/t.co/ngm2FENDH2 ⏰ Thursday 28 Feb at 7AM PST | 10AM EST | 4PM CET @ErikKoffijberg @k_degeling @mivandev
1
6
19
1,642
Michiel van de Ven retweeted
@ErikKoffijberg, @mivandev and I will run our #DiscreteEventSimulation course again in January 2023! Make sure to secure your spot for this unique learning opportunity. More information in the brochure: utwente.nl/en/bms/htsr/educa…
1
3
Michiel van de Ven retweeted
Did you know #DiscreteEventSimulation can represent complex dynamics of #clinicalpractice? There’s more to learn at tomorrow’s short course, beginning at 9AM EDT. @k_degeling Hendrik Koffijberg @utwenteEN @#HEOR ow.ly/h1pX50IGWhV
3
3
Michiel van de Ven retweeted
Next week, @ErikKoffijberg and I will present a virtual short course on "Learning and Applying Discrete Event Simulation", in which we will cover theoretical aspects and provide hands-on demonstrations! There is still time to register: ispor.org/conferences-educat…
2
3
Introduction to Simulation with SimPy by @dariow1 buff.ly/3NyFzHi
3
23
I've written about creating a health economic Discrete-Event Simulation in Python. Amongst others, my illustration includes objected-oriented programming, stochasticity, and parallel processing. Full code is available on my github. mivandev.nl/post/simpy/ #healtheconomics
2
6
22
Our quantitative scenario study on possible future developments that may facilitate or impede the use of WGS in oncology has been published: rdcu.be/cjXfU @ErikKoffijberg @ManuelaJoore @ValescaRetel @WimvanHarten @maartenijzerman
1
2
UT wetenschapper Maarten IJzerman onderzoekt een nieuwe studie over het gebruik van biomarker tests voor longkankerpatiënten. In deze studie heeft zijn team de significante variatie en timing voor NSCLC patiënten gevonden. Meer in het artikel hieronder 👇 https://nitter.cf/t.co/Ih6AGQeGDR
3
4
Michiel van de Ven retweeted
Investigators report in @JMDiagn that whole #genomesequencing, instead of #biomarker testing may streamline selection of appropriate therapies: https://nitter.cf/t.co/UjCwbJc2Nb #medicine #research #precisionmedicine @ASIPath @AMPath